Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Toxicity studies reported for new expectorant from SS Pharm.

Oct. 17, 1997

Byk Gulden describes new agents for asthma

Oct. 17, 1997

CRP-derived peptides for chronic inflammatory disorders developed at Yeda

Oct. 16, 1997

New bronchodilators from Nippon Suisan

Oct. 16, 1997

FDA actively reviewing TOBI

Oct. 13, 1997

Mutual Recognition Procedure concludes for Nasonex

Oct. 13, 1997

Vanguard Medica and Abbott collaborate on development of new oral asthma therapy

Oct. 13, 1997

PathoGenesis receives grant for new antibiotic for CF infections

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.